Global Intestinal Ischemia Market, By Type (Colon Ischemia, Chronic Mesenteric Artery Ischemia, Others), Treatment Type (Medications, Surgery), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Intestinal Ischemia Market Analysis and Size
The global intestinal ischemia market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. Factors such as high prevalence of cardiovascular disorders and adopting a sedentary lifestyle are prominent factors driving the global vasodilators market. In addition, launches of drugs annually and improvement in treatment are some of the impacting factors that drives the market growth. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global intestinal ischemia market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Intestinal ischemia is a type of condition that causes necrosis or tissue death due to inadequate blood supply to the intestine. The exact cause is unknown though; it is predicted that it likely occurred when there is defect in the bladder's protective lining or the patient has autoimmune reaction, heredity, infections and allergy. The major sign and symptoms include pain in the pelvic region, persistent or urgent need to urinate and painful intercourse. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period
Intestinal Ischemia Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Colon Ischemia, Chronic Mesenteric Artery Ischemia, Others), Treatment Type (Medications, Surgery), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Johnson & Johnson Services, Inc (U.S.), Sanofi (France), Bayer AG (Germany), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Melinta Therapeutics, INC (U.S.), Merck & Co., Inc. (U.S.), Allergan (Ireland), Pfizer Inc (U.S.), Novartis AG (Switzerland), Mylan N.V (U.S.), Lupin (India), Amneal Pharmaceuticals Inc (U.S.), Zydus Cadila (India), Bausch Health (Canada), Teva Pharmaceutical Industries Ltd (Israel)
|
|
Market Opportunities
|
|
Global Intestinal Ischemia Market Dynamics
Drivers
- Increase in Geriatric Population
The elderly population is expected to boost the patient population globally, which in turn accelerates the global intestinal ischemia market in the forecast period. According to the WHO, the global elderly population is expected to reach around 2 billion by 2050 from 617 million in 2015. This boost the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increased Mergers and Acquisitions
Increased mergers & acquisitions to develop and launch advanced drugs and treatment are helping in the growth of the market. Several drug launches and drug approvals from FDA are expected to create lucrative growth opportunities during the forecast period 2022-2029. For instance, Faraday Pharmaceuticals announced positive results from phase II trials of FDY-5301 for ischemia reperfusion injury treatment following a STEMI heart attack in November 2019. Its role is to destroy the hydrogen peroxide that is generated naturally as a result of acute ischemia reperfusion injury.
Restraints/Challenges
- Lack of Skilled Professionals
Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global intestinal ischemia market over a forecast period.
- High Cost
The huge expenditure of the treatment methods surely hamper the market growth.
This global intestinal ischemia market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global intestinal ischemia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Intestinal Ischemia Market Scope
The global intestinal ischemia market is segmented on the basis of type, treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Colon Ischemia
- Chronic Mesenteric Artery Ischemia
- Others
Treatment Type
- Medications
- Surgery
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Intestinal Ischemia Market Regional Analysis/Insights
The global intestinal ischemia market is analysed and market size insights and trends are provided by type, treatment type, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global intestinal ischemia market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to the global leaders in research and development activities, established framework of approval process and increase in patient awareness level.
Asia-Pacific dominates the market due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives and specialist communities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Intestinal Ischemia Market Share Analysis
The global intestinal ischemia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global intestinal ischemia market
Key players operating in the global intestinal ischemia market include:
- Johnson & Johnson Services, Inc (U.S.)
- Sanofi (France)
- Bayer AG (Germany)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Melinta Therapeutics, INC (U.S.)
- Merck & Co., Inc. (U.S.)
- Allergan (Ireland)
- Pfizer Inc (U.S.)
- Novartis AG (Switzerland)
- Mylan N.V (U.S.)
- Lupin (India)
- Amneal Pharmaceuticals Inc (U.S.)
- Zydus Cadila (India)
- Bausch Health (Canada)
- Teva Pharmaceutical Industries Ltd (Israel)
SKU-